Press Releases

MONMOUTH JUNCTION, N.J., Nov. 6, 2019 /PRNewswire/ -- CytoSorbents Corporation (NASDAQ: CTSO), a critical care immunotherapy leader commercializing its

GATINEAU, Quebec, Nov. 6, 2019 /PRNewswire/ -- The Alliance for Safe Biologic Medicines (ASBM) today released an abstract from a forthcoming white paper that provides a comprehensive overview of the evolution of the European biosimilars market.  The

IRVINE, Calif., Nov. 6, 2019 /PRNewswire/ -- Inari Medical, Inc. today announced the presentation of early outcomes from the ClotTriever Outcomes Registry ("CLOUT") using the ClotTriever Mechanical Thrombectomy System for treatment of acute and chronic lower extremity deep vein thrombosis ("DVT"). Initial results for the first 50 patients were presented by prin

NEW YORK and SHANGHAI, Nov. 6, 2019 /PRNewswire/ -- Cellular Biomedicine Group Inc. (NASDAQ: CBMG) ("CBMG" or the "Company"), a bi

VANCOUVER, Nov. 6, 2019 /PRNewswire/ - CRH Medical Corporation (the "Company") (TSX: CRH) (NYSE American: CRHM), announces that it has received approval from the Toronto Stock Exchange ("TSX") of its Notice of Intention to renew its existing Normal Course Issuer Bid (the "Bid").Pursuant to the Bid, the Company may purchase for canc

DUBLIN, Nov. 6, 2019 /PRNewswire/ -- November 6, 2019 – Theravance Biopharma, Inc. (NASDAQ: TBPH) announced today that management will participate in a corporate presentation at the 28th Annual Credit Suisse Healthcare Conference on Tuesday, November 12, 2019, at 3:00 p.m. MT. The conference will take

NEWARK, Calif., Nov. 6, 2019 /PRNewswire/ -- Protagonist Therapeutics, Inc. (Nasdaq:PTGX) today reported its financial results for the third quarter ended September 30, 2019, and provided a corporate update.

BAD HOMBURG, Germany, Nov. 6, 2019 /PRNewswire/ -- Fresenius SE & Co. KGaA (Frankfurt stock exchange : FRE, US ADR program : FSNUY) based in Bad Homburg, Germany, and focused on global healthcare products and services for dialysis, hospitals and outpatient medical care, today announced that Markus Geo

LAS VEGAS, Nov. 6, 2019 /PRNewswire/ -- VIVA Physicians, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the final round of 21 highly anticipated late-breaking clinical trial results at VIVA19 hosted at Wynn Las Vegas.

PHILADELPHIA, Nov. 6, 2019 /PRNewswire/ --   Financial and Business Highlights:Net Sales, Profitability Exceeded Expectations Launched First-to-Market Posaconazole Expanded Pipeline with Significant Future Opportunities:      • Lev